Travers H C, Brewer J O, Smart N J, Wajed S A
Department of Upper Gastro-Intestinal Surgery, Royal Devon and Exeter Hospital, Barrack Road, Exeter, EX2 5DW, UK.
University of Exeter Medical School, Exeter, UK.
Hernia. 2016 Apr;20(2):311-20. doi: 10.1007/s10029-015-1390-5. Epub 2015 May 8.
To evaluate the safety, efficacy and durability of selective integration of porcine dermal collagen (Permacol) biologic mesh for crural re-construction in large or complex para-oesophageal hernia surgery.
Surgical repair of para-oesophageal herniation has been associated with high rates of failure. The utilisation of prosthetic mesh is controversial with complications including erosion and fistulation. Long-term outcomes for biologic mesh crural augmentation are unclear.
A retrospective analysis of patients who underwent a biologic mesh (Permacol) augmented cruroplasty in the repair of large and/or complex para-oesophageal hernia was performed utilising the prospectively maintained oesophago-gastric database at the Royal Devon and Exeter Hospital between October 2004 and January 2013. This technique was selectively used for patients where the lateral extent of the diaphragmatic-crural defect prevented the fashioning of a sound, tension-free repair with sutures alone, or previous surgery had failed. Successful outcome was defined by resolution of symptoms and structural integrity of the repair.
Fifty one procedures were performed on 49 patients (15 male), median age 75 (range 25-91). Post-operative morbidity included 2 (3.9%) oesophageal injuries managed conservatively, and 2 (3.9%) patients who suffered early repair breakdown requiring immediate surgical re-intervention. Four patients (8%) required endoscopic dilatation due to dysphagia, one (2%) in the early post-operative phase. The median follow-up was 36 months (range 6-105). All patients reported initial symptomatic resolution. Two patients (4%) were demonstrated to have breakdown of their repair during the follow-up period, both of whom underwent revision mesh-augmented surgery and are re-incorporated in this series. Late-onset dysphagia in two (4%) patients may be mesh-related, but no other complications were observed and a Kaplan-Meier analysis of this series predicts a symptom-free rate of approximately 94% at 5 years.
The selective integration of biologic mesh to augment the crural repair in para-oesophageal hernia with extensive diaphragmatic defects appears to be safe, effective and infers the potential of long-term satisfactory outcomes.
评估猪真皮胶原蛋白(Permacol)生物补片选择性整合用于大型或复杂食管旁疝手术中膈肌脚重建的安全性、有效性和耐久性。
食管旁疝的手术修复失败率较高。人工补片的使用存在争议,其并发症包括侵蚀和瘘管形成。生物补片增强膈肌脚的长期效果尚不清楚。
利用皇家德文郡和埃克塞特医院前瞻性维护的食管胃数据库,对2004年10月至2013年1月期间接受生物补片(Permacol)增强膈肌脚成形术修复大型和/或复杂食管旁疝的患者进行回顾性分析。该技术选择性用于膈肌脚缺损的外侧范围妨碍仅用缝线进行可靠、无张力修复的患者,或先前手术失败的患者。成功的结果定义为症状缓解和修复结构完整。
对49例患者(15例男性)进行了51次手术,中位年龄75岁(范围25 - 91岁)。术后并发症包括2例(3.9%)经保守治疗的食管损伤,以及2例(3.9%)早期修复失败需要立即手术再次干预的患者。4例患者(8%)因吞咽困难需要内镜扩张,其中1例(2%)在术后早期。中位随访时间为36个月(范围6 - 105个月)。所有患者最初均报告症状缓解。2例患者(4%)在随访期间修复失败,均接受了补片增强翻修手术,并重新纳入本系列。2例(4%)患者出现迟发性吞咽困难可能与补片有关,但未观察到其他并发症,本系列的Kaplan - Meier分析预测5年时无症状率约为94%。
在有广泛膈肌缺损的食管旁疝中,选择性整合生物补片增强膈肌脚修复似乎是安全、有效的,并具有长期获得满意结果的潜力。